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-1852 TAAGTTGATAAAGCTAATTTCTCATTTTAGCTACCATCGCTAGTAATCGTGGCAATAACT
-1792 ACCCTAACTATAGCATTTATTGCTACCAAATAAAATTTGGCAGCTAATCATAATTTTTTG
-1732 TCATGAATCAATAGTTATTGTAGCAATAGTTATCTCTTAGCCACAATAAATTATTTAAAA
-1672 TAAAATATTATAGCTAAATAAATATTTTTGCTTTAAGTTCTAAAAGGTTGTGGCAATAGT

~1612
-1552
—1492
1432
1372
-1312
-1252
r1192
-ll32
-1072
—1012
-952
-892
—832
-772
—712
—652
~592
—532
—47Z

TAAATGATATAGTCACAGATTTATTGGTATAATTGAATTATGTTGCTAATTTCTTAGTTT
TTTGCCACGAGTTAAAAATTACCAATAGCTATAGTAACTTTTTAATCACAATAAAATATT
TGAAAGAAAATATTGTAGCTAAATGAATATTTTTTCCTTCAAGTTATTAAAAGTTGTGGC
AATATAGGTTAAATTAGCCACATGTTTCTTGCTTTAATAGAATTTTGTAGCTAATCATTA
ACTTTTACCACGAGTTGAACTTAATATAACAACAATAACCTTTTAACCATAATAAAGCGA
TTTAAATCAAATATTACTAAATAAATAACTTTGCTTTCAAGTTTCTATAAAATCATGGCA
ATAGTCATTACGATAAAATGATATAACCACGAATATATTGCAACGATAAATTCTGTAACT
AATCATTAGTTTTTGCGACGAGGTAAATTTTCCGTCACAGTAGCAATCTTCTAGGCACAT
TAAAAATTTGAAACAAAATTTTGTAGTCAAATAAATATTTATCTTCTTATTTTAAGAAAA
TAAAAATAGTTAGATAATAGTTACTACTATTTGTCATGAAAATATCAATAGATACAAATT
TAAAGTGACTATAAATTTACGAGTTTACTATACTTTAGTCGTACAGTTTGCAATAATAGT
ATTTTAACCACAATTAGTTATATGTACAAAATAACATAAGTGAATAACTTTTTTTCAATG
AGAAAATAAGAGTTGCTCAAACAATATCAAGTTACAAAAATTTAATTTTAACTGTAAAAG
TTATATTTTTCCAAAATAACATAAACTATAGTAATTATATATAGTTTGAAGTATTAATAA
AATTTAAATATGCAAAAGTTAATTTTAATAAACCATTTGTATGCCTAACTTGTAGCCTCT
AAACTATTTTATTTGCTTTATTTATCAAACTCATATTTTATTTTATTGCACCTTGTTAGT
TTTGGACGTTAATTATATATATTTGGTGTAAAATTTAAAATATATTAACATTTGTGGAGA
ATTTATGTATGCCTGGTTCTTAACTATTTTTTTTTATATAACTGGTTAGAGTAATTTCTT
ATATTTCAGTATTTATTTTTAAATAAGTCCTCATAAATTGAAGACTTTAAAAGTTTTTGT
GTCATTCCTCTTTTTATTTAAGAAATTGAAGAATTCCGCTAAATTTCATATTTCCGCTGT

~412 TATTTAACTGTTTATTTCCCTTGTTAATATAATTGGTAAGAAGTTTTAAAATAAAGGAGT

-35Z TAATGATTTTCTAGGTTCATGGCTTGCCTAGCTTCTACGAGTAAGCGCCATCACGACTCC
—292 CGAGGATAAGGAAATCCGGGTCGTAGCATTCACTCACAAAAATTACTAAAAACAAAGTTT

-232 ACCCTTCTCCCAAAAGTAAATTTCATATTTGGCTCCACATAATGTGTTQMlGAGTCA/XG
-172 TGAAGTACTTTTCATGACAAAAAAAAGTTGCTGAAAAATGCATATCTCATATTTTTTTTT
~112 TAGAGAAATCQTFTCTTGCCTAAACGAAAGCC TA TAAAAGAGCATATATTGCAACAAC

—52 AGTTTQCAGAAACTATCAAGTCAAATAATCCCCCCTTTAATTCCCTCCCAAA?QC/XGTT
9 CTTCAACTTCTTTTCCCTTTTCCTTTTTGTGTCATTTCTCTTTTTATTTAAGAAATGGAA
69 GAATTCCAATAGCCAAACCAAAAGATTGCCTCCAGGTCCATGG

FIG.2
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PLANT TRICHOME GLAND SPECIFIC

suggests a close relationship betWeen trichomes and root
hairs. From this vieWpoint, aerial trichomes and subterra

PROMOTER SEQUENCE

nean “trichomes” could be said to cover or nearly cover the

surfaces of most plants. HoWever, While trichomes and root
hairs may resemble each other in morphology, their genetic
determinants may differ. Both trichomes and root hairs

CONTINUING DATA

This application claims the bene?t of priority to US.
Provisional Application No. 60/191,088, ?led Mar. 22,
2000, Which is incorporated by reference herein in its

develop projections from protodermal cells. Glandular struc
tures of trichomes arise from a series of anticlinal and

entirety.

periclinal divisions to form supporting auxiliary cells and
FIELD OF THE INVENTION

10

The present invention relates to a trichome speci?c regu
latory sequence such as a promoter, and heterologous con

structs comprising the trichome speci?c regulatory sequence
and DNAs encoding a single or multiple polypeptide of

subepidermal cells.
15

interest. The present invention is also related to transgenic
expression of a polypeptide(s) of interest in the trichome.

20

bearing of trichomes or hairs. The morphology of these
structures can vary greatly With tissues and species. Indeed,
the botanical literature is said to contain more than 300

descriptions (uniseriate, capitate-sessile, etc.) to characteriZe
various morphological types. These characteristics have
often been used in plant classi?cation. Functionally, tri
chomes may be simple hairs Which deter herbivores, guide
the path of pollinators or affect photosynthesis, leaf
temperature, or Water loss through increased light re?ec
tance as in desert species. Or, they may be more specialiZed

Hutvagner et al., Gene 188 (1997) 247—252 describes the
potato P450 gene. The function, tissue speci?city and pro
moter of this potato gene is not presented or discussed in the
paper.

BACKGROUND OF THE INVENTION
Most surfaces of most plants are said to be pubescent, or

glands as in the case of Cannabis. The appearance of glands
atop supporting cells and the occurrence of exudate around
gland cells has suggested to most observers that secretions
are produced in gland cells and not by other epidermal or

25

Clark et al., Plant Molecular Biology 33 (1997) 875—885
describes another P450 gene isolated Nepeta racemosa that
hybridiZes to RNA from trichomes but not that prepared
from leaves stripped of trichomes. This gene shoWs 36 and

45 to 50% homology to 1—31, protein and DNA levels,
respectively. No promoter is described in this paper.
Wagner, Plant Physiol. 96 (1991) 675—679 provides some
brief background on plant glanded trichomes.

In order to produce genetically engineered polypeptides in
trichomes there is a need to make a trichome speci?c
30

regulatory sequence that alloWs for targeting of gene expres

sion speci?cally in trichome glands.

tissues (glandular secreting trichomes) Whose principal
SUMMARY OF THE INVENTION

function(s) may be to produce pest- or pollinator-interactive
chemicals Which are stored or volatiliZed at the plant sur

face. It has been suggested that in some desert species the

principal role of glandular secreting trichomes is to produce

It is an object of the present invention to provide an
35

such high levels of exudate that it forms a continuous layer
on the plant surface. This layer may increase light re?ec
tance and thereby reduce leaf temperature.

It is the glandular, merocrine, secreting trichome type
Which often produce and accumulate terpenoid oils that is

a polynucleotide Which is a variant or fragment of the

40

the focus of this application. Other secretory tissues occur
ring on or in plants include salt glands, salt hairs, nectary and

slime glands, resin ducts, and osmophores (perhaps respon
sible for fragrances in ?oWers). Useful modi?cation might

45

be genetic manipulation of an enZyme to alter the chemical
nature of exudate for the purpose of enhancing disease
resistance, enhancing attractiveness to pollinators, or to

polynucleotide set forth in SEQ ID NO:1, Wherein said
variant or fragment has trichome speci?c transcriptional
regulatory activity; or
a polynucleotide sequence Which hybridiZes to the poly
nucleotide of SEQ ID NO:1 under 5><SSC and 42° C. Wash
conditions.
The nucleic acid may be a polynucleotide comprising the
sequence set forth in SEQ ID NO:1. The nucleic acid may

further comprise a polynucleotide encoding a polypeptide.
The polypeptide may be a disease- or pest-resistance con

ferring protein. The polypeptide may be a pharmaceutical

expand the metabolism of secretory cells to include synthe

compound. The polypeptide may function to alter horticul
tural or food plants. The polypeptide may also be a phyto
toxic protein, or a protein highly sensitive to modi?cation

sis of compounds or intermediates not normally formed. It

is important to point out that the potential of secreting
trichomes to accumulate exudate is highly signi?cant in

during isolation from plant tissue homogenates. Any

certain plants Where, under optimal conditions, secreted

polypeptide at all can be used With the trichome speci?c

products can reach a level of 10 to 30% of the dry Weight of

leaves. Glandular trichome exudates usually contain terpe

isolated nucleic acid molecule comprising:
a polynucleotide set forth in SEQ ID NO:1;

55

regulatory sequence of the invention. The trichome speci?c

easily stored in large amounts Within the cell. Therefore, if

regulatory sequence also encompasses a promoter sequence.
Another object of the invention is to provide a composi

it Were desirable to manipulate plants to produce or over

tion comprising a polypeptide made from expression of the

nes and essential oils, as Well as lipophilic components not

produce a compound in this class of biochemicals, the
secreting trichome system, Which amasses secretions outside
of gland cells, may be more amenable to overproduction
than one requiring intracellular storage.
Esau, Plant Anatomy, John Wiley & Sons, N.Y. has
de?ned trichomes as “epidermal appendages of diverse

60

form, structure and functions . . . represented by protective, 65

supporting, and glandular hairs, by scales, by various
papillae, and by absorbing hairs of roots.” This de?nition

above-mentioned nucleic acid, and a trichome gland exu
date.
The present invention also relates to a vector comprising
a replicable vector and the above-mentioned polynucleotide
inserted into said vector.
The vector may be preferably a cloning or expression
vector, or a plant vector, preferably a binary vector.
The present invention also relates to a cell containing the
above-mentioned vector. Preferably, the cell is a plant cell.

US 6,730,826 B2
4

3
The present invention also provides for a plant comprising
the above-mentioned nucleic acid.
The present invention is also related to a method for

-continued

expressing a polypeptide comprising constructing a vector
comprising a trichome speci?c regulatory sequence and a
nucleic acid encoding a polypeptide, and inserting said
vector into a plant, Wherein said polypeptide is expressed

trichome speci?cally.
BRIEF DESCRIPTION OF THE DRAWINGS

10

The present invention Will become more fully understood

from the detailed description given herein beloW, and the
accompanying draWings Which are given by Way of illus
tration only, and thus are not limitative of the present

15

shoWs light microscopic vieWs of TL 1068 epidermis shoW

ing peltate glandular trichomes. Tissue “C” is epidermis
epidermis from a similar aged leaf of a plant expressing the
GUS reporter gene driven by a trichome-speci?c promoter.
Note the occurrence of GUS stain in glands only. Some
slight blue color Was also found in the stalk cell immediately
attached to the gland. This may represent leakage of stain
during tissue ?xation, or movement betWeen the gland and

One-letter

abbreviation

symbol

Methionine
Ornithine

Met
Orn

Phenylalanine

Phe

F

Proline
Serine
Threonine

Pro
Ser
Thr

P
S
T

Tryptophan
Tyrosine

Trp
Tyr

W
Y

Valine

Val

V

Speci?cally Exempli?ed Polypeptides
The present invention relates to DNA comprising the

invention, and Wherein;
FIG. 1(A) shoWs dissecting microscopic vieWs and (B)
from leaf of a non-transformed plant, and “P-GUS” is

Three-letter

Amino Acid

20

trichome speci?c regulatory sequence operably linked to
DNA encoding any polypeptide or multiple polypeptides.
The polypeptide can be heterologous, preferably a plant
protein, but not necessarily limited to plant proteins. The
polypeptide can be a variant or fragment of a polypeptide.

Preferably, the polypeptide is expressible in the trichome
gland. Expression and recovery from a recombinant organ
ism can be by any convenient method.
Substitutions, Additions and Deletions
25

As possible variants of the polypeptide, the polypeptide
may have additional individual amino acids or amino acid

the ?rst stalk cell Within the vacuolar-tubular continuum. No
stain Was found in root, stem, or any other tissue (not

sequences inserted into the polypeptide in the middle thereof

shoWn).
30

long as the polypeptide possesses the desired physical and/or
biological characteristics. LikeWise, some of the amino acids

35

or amino acid sequences may be deleted from the polypep
tide so long as the polypeptide possesses the desired physi
cal characteristics. Amino acid substitutions may also be
made in the sequences so long as the polypeptide possesses
the desired physical and biochemical characteristics.

FIG. 2 (SEQ ID NO:3) shoWs a DNA sequence of

and/or at the N-terminal and/or C-terminal ends thereof so

upstream regulatory region of a tobacco trichome speci?c
promoter (TSP), along With ?rst 111 base pair sequence of
the ?rst exon (SEQ ID NO:1). The transcription start point,
and the putative translation start are in bold letters and

underlined. The putative TATA box and putative CAAT box
sequences are italiciZed and underlined. SEQ ID NO:2

Sequence Identity

shoWs the upstream sequence Without the protein coding

TWo sequences are said to be “identical” if the sequence
of residues is the same When aligned for maximum corre

region.
FIG. 3 shoWs a deletion analysis of the tobacco TSP. The

activity of full-length promoter (—1852) Was set at 100% and

spondence as described beloW. The term “complementary”
40

used to de?ne the relative activities of further deletions.
DETAILED DESCRIPTION OF THE
INVENTION
Abbreviations

applies to nucleic acid sequences and is used herein to mean
that the sequence is complementary to all or a portion of a

reference polynucleotide sequence.
Optimal alignment of sequences for comparison can be
conducted by the local homology algorithm of Smith and
45

Waterman,Aa'd. Appl. Math, 2:482 (1981), by the homology
alignment method of Needleman and Wunsch, J. M01. Bi0l.,
48:443 (1970), by the search for similarity method of

Abbreviations for amino acids used herein are conven

tionally de?ned as described herein beloW unless otherWise
indicated.

Pearson and Lippman, Proc. Natl. Acad. Sci. USA, 85 12444
(1988), or the like. Computer implementations of the above
algorithms are knoWn as part of the Genetics Computer

Group (GCG) Wisconsin Genetics SoftWare Package (GAP,
Three-letter

One-letter

abbreviation

symbol

Alanine

Ala

A

Arginine

Arg

R

Asparagine

Asn

N

Aspartic acid

Asp

D

Asparagine or aspartic acid

Asx

B

Cysteine
Diaminopropionic acid

Cys
Dpr

C

Glutamine
Glutamine acid
Glutamine or glutamic acid

Gln
Glu
Glx

Q
E
Z

Glycine

Gly

G

Histidine
Isoleucine
Leucine

His
Ile
Leu

H
I
L

Lysine

Lys

K

Amino Acid

BESTFIT, BLASTA, FASTA and TFASTA), 575 Science
Drive, Madison, Wis.
“Percentage of sequence identity” is determined by com
55

60

paring tWo optimally aligned sequences over a comparison
WindoW, Wherein the portion of the sequence in the com
parison WindoW may comprise additions or deletions (i.e.
“gaps”) as compared to the reference sequence for optimal
alignment of the tWo sequences being compared. The per

centage identity is calculated by determining the number of
positions at Which the identical residue occurs in both

65

sequences to yield the number of matched positions, divid
ing the number of matched positions by the total number of
positions in the WindoW and multiplying the result by 100 to
yield the percentage of sequence identity. Total identity is
then determined as the average identity over all of the
WindoWs that cover the complete query sequence.

US 6,730,826 B2
5
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Post-translational Modi?cation
Also included Within the scope of the present invention

sequence that is a variant from that of the exempli?ed
nucleotide sequence, but represents the same chromosomal
locus in the organism. In addition to those Which occur by

are polypeptides or fragments or derivatives thereof Which

are differentially modi?ed during or after translation, e.g., by

normal genetic variation in a population and perhaps ?xed in

glycosylation, proteolytic cleavage, phosphorylation,

the population by standard breeding methods, allelic vari

methylation, amidation of glutamic acid, aspartic acid and
C-terminal carboxyl groups.
Fusion Polypeptides

preferred allelic variant is one that is found in a naturally

The polypeptide of the present invention may be

variants are either silent or expressed. A silent allele is one

expressed as a fusion polypeptide or chimeric polypeptide
With a second polypeptide as transcriptionally expressed
from a single trichome speci?c regulatory sequence. The
second polypeptide Will usually impart an additional prop

ants can be produced by genetic engineering methods. A

occurring organism, including a laboratory strain. Allelic
10

notype of the trait represented by the locus.
In addition to the above, the preferred upstream region of
the trichome speci?c upstream region may be located in the

erty or characteristic to the fusion polypeptide Which is not

possessed by the polypeptide of the present invention.
Production of Recombinant Polypeptide
Recombinant polypeptide can be produced by a process
Which comprises culturing the transformed cell or microor
ganism described herein under conditions Which alloW
expression of the polypeptide as transcriptionally regulated
from the trichome speci?c regulatory sequence of the

15

20

invention, optionally recovering the thus expressed polypep
25

A nucleic acid sequence “encodes” or “codes for” a

referred to. The nucleic acid can be DNA or RNA. Unless
otherWise speci?ed, a nucleic acid sequence that encodes a
30

representative of mRNA, including untranslated portions
35

sequences. Methods for saturating a particular DNA
sequence With random mutations and also for making spe

may also contain some small amounts of contaminating
40

Puri?cation of Recombinant Polypeptide

ci?c site directed mutations are knoWn in the art; see eg

Sambrook et al supra, Chapter 15.

HybridiZable Variants

is also directed to these neW or isolated polypeptides Which

chome speci?c regulatory sequence.

thereof.
DNA Modi?cation

The DNA is readily modi?ed by substitution, deletion or
insertion of nucleotides, thereby resulting in novel DNA

tide. The polypeptide produced by recombinant techniques

are produced under the transcriptional control of the tri

polypeptide includes both the transcribed strand and the
mRNA or the DNA representative of the mRNA. An “anti
sense” nucleic acid is one that is complementary to a strand

Harbor, NY, Chapters 16, 17 and 18.

materials from the microorganism, cells and/or fermentation
system in Which it Was produced. Thus, the present invention

ID NO:1 or the DNA in the region of —1273 to —1123 from
the putative translation start site of SEQ ID NO:1.

polypeptide if it directs the expression of the polypeptide

by Cold Spring Harbor Laboratory Press, Cold Spring
The polypeptide produced in this manner may be different
from natural polypeptide in that it may be free of other
polypeptides or materials Which occur in natural polypep

—1273 to —1123 upstream of the putative translation initia
tion site. Thus, in one embodiment, the present invention is
directed to utiliZing a nucleic acid comprising a nucleic acid
that has 75% similarity to the DNA depicted in SEQ ID
NO:1 or has such similarity to the —1273 to —1123 region of
SEQ ID NO: 1. More preferably, there is 80% similarity. Still
more preferably, there is 85% similarity. Even more

preferably, there is 90% similarity, and most preferably,
there is 95% similarity to either the DNA depicted in SEQ

tide and optionally purifying the recovered polypeptide. In
processes for the synthesis of the polypeptide, DNA Which
encodes a polypeptide is ligated into a replicable
(reproducible) vector and operably linked to the trichome
speci?c regulatory sequence. The vector is used to transform
host cells, and the polypeptide is recovered from the culture.
Suitable replicable vectors are selected depending upon the
particular host cell chosen. Suitable processes are knoWn in
the art and are described, for example, in Sambrook et al,
Molecular Cloning: A Laboratory Manual, 2nd Ed. c. 1989

that does not affect the phenotype of the organism. An
expressed allele results in a detectable change in the phe

The DNA molecule can comprise a nucleotide sequence
of SEQ ID NO:1, or can comprise a nucleotide sequence of
45 a nucleotide sequence that hybridiZes to a DNA molecule of

SEQ ID NO:1 under salt and temperature conditions equiva

Recombinant polypeptide can be recovered from cultures

by lysing the cells to release recombinant polypeptide Which

lent to 5><SSC and 42° C. and that possesses the ability to

is present inside the cells. Initially, cell debris can be

transcriptionally regulate the expression of a gene speci?

separated by centrifugation. The remaining debris and the

cally in the trichome. See Chapters 11 and 12 of Sambrook
et al, supra.

supernatant are then repeatedly treated With solvents in
Which the cell debris are soluble but in Which the recombi
nant polypeptide is not soluble to thereby precipitate recom

Recombinant DNA Constructs

Recombinant DNA constructs comprising one or more of
the DNA or RNA sequences described herein and an addi
tional DNA and/or RNA sequence are also included Within
combined With other procedures including ?ltration, dialysis
55 the scope of this invention. These recombinant DNA con
and/or chromatography to obtain a pure product.
DNA and RNA
structs have sequences Which do not occur in nature or exist
in a form that does not occur in nature or exist in association
The invention encompasses DNA including, but not lim
With other materials that do not occur in nature. The DNA
ited to, that shoWn in SEQ ID NO:1. including variants and

binant polypeptide. These procedures can be repeated and

fragments thereof that have trichome speci?c transcriptional
activity. The sequence of the regulator Which has actually

60

and/or RNA sequences described herein above are “operably
linked” With other DNA and/or RNA sequences. DNA

been sequenced is shoWn in SEQ ID. NO:1. The present

regions are operably linked When they are functionally

invention also includes genomic DNA containing or com
prising the requisite nucleotide sequences as Well as corre

related to each other. For example, DNA for a presequence
or secretory leader is operably linked to DNA for a polypep

sponding RNA and antisense sequences.
Cloned DNA Within the scope of the invention also

includes allelic variants of the speci?c sequences presented
in the attached Sequence Listing. An “allelic variant” is a

65

tide if it is expressed as a preprotein Which participates in the
secretion of the polypeptide; a promoter is operably linked
to a coding sequence if it controls the transcription of the
sequence; or a ribosome binding site is operably linked to a

US 6,730,826 B2
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coding sequence if it is positioned so as to permit translation.

tion events (all necessary DNAs present on separate vectors
that are introduced into plants or plant cells independently).
Traditional breeding methods can subsequently be used to

Generally, operably linked means contiguous (or in close
proximity to) and, in the case of secretory leaders, contigu
ous and in reading phase.

incorporate the entire pathWay into a single plant. Speci?c

Vectors
The invention is further directed to a replicable vector

methods for transforming a Wide variety of dicots and
obtaining transgenic plants are Well documented in the
literature.

containing cDNA Which codes for a polypeptide and Which

Successful transformation and plant regeneration have

is capable of expressing the polypeptide under the transcrip

been achieved in the monocots as folloWs: asparagus

tional control of a trichome speci?c regulatory sequence.
The present invention is also directed to a vector com

10

prising a replicable vector and a DNA sequence correspond
ing to the above-described gene inserted into said vector.
The vector may be an integrating or non-integrating vector

and is conveniently a plasmid.
Transformed Cells

15

The invention further relates to a transformed cell or

microorganism containing cDNA or a vector Which codes
for the polypeptide or a fragment or variant thereof and

Which is capable of expressing the polypeptide.
Plant Cell Expression Systems

20

Plant Vectors

In plants, transformation vectors capable of introducing
DNAs under the control of a trichome speci?c regulatory
sequence are easily designed, and generally contain one or
more DNA coding sequences of interest under the transcrip
tional control of 5‘ and 3‘ regulatory sequences. Such vectors

25

generally comprise, operatively linked in sequence in the 5‘
to 3‘ direction, a trichome speci?c promoter sequence that
directs the transcription of a doWnstream heterologous struc
tural DNA in a plant; optionally a 5‘ non-translated leader

30

sequence; a nucleotide sequence that encodes a protein of
interest; and a 3‘ non-translated region that encodes a

35

ing said protein. Plant transformation vectors also generally

(1992)); orchardgrass (Dactylic glomerata; Horn et al, Plant
Cell Rep., 7:469 (1988)); rice (Oryza saliva, including
indica and japonica varieties; Toriyama et al, Bio/
Technology,6:10 (1988); Zhang et al, Plant Cell Rep., 7:379
(1988); Luo and Wu, Plant Mol. Biol. Rep., 6:165 (1988);
Zhang and Wu, Theor. Appl. Genet., 76:835 (1988); Chris
tou et al, Bio/Technology,9:957 (1991)); rye (Secale cereale;
De la Pena et al, Nature, 325:274 (1987)); sorghum
(Sorghum bicolor; Cassas et al, Proc. Natl. Acad. Sci. USA;
90:11212 (1993)); sugar cane (Saccharum spp.; BoWer and
Birch, Plant J., 2:409 (1992)); tall fescue (Festuca aruna'i
nacea; Wang et al, Bio/Technology, 10:691 (1992)); turf
grass (Agrostis palustris; Zhang et al, Plant Cell Rep, 13:1
(1993)); and Wheat (Triticum aestinum; Vasil et al, Bio/
Technology, 10:667 (1992); Weeks et al, Plant Physiol.,
102:1077 (1993); Becker et al, Plant J., 5:299 (1994)).

genuses: Populus, Ermophilia, Lycopersicon, Nicotiana,
Cannabis, Pharbitis, Apteria, Psychotria, Mercurialis,

Chrysanthemum, Polypodium, Pelargonium, Polytrichiales,

sequences include a transcription initiation start site, a

ribosome binding site, an RNA processing signal, a tran
40

Vectors for plant transformation are described (Schardl et

al., Gene 61, 1—14, (1987); Plant Mol Biol., 25:989—994
(1994)). Particularly useful vectors for this invention
include, but are not limited to (pKYLX71, pPZP family,

pKYLX71-35S2).

Rhodes et al, Science, 240:204 (1988); Gordon-Kamm et al,
Plant Cell, 2:603 (1990); Fromm et al, Bio/Technology,
8:833 (1990); KoZiel et al, Bio/Technology, 11:194 (1993));
oats (Avena saliva; Somers et al, Bio/Technology, 10:1589

Particularly useful plants for exploiting the trichome
gland speci?c promoter include plants and ferns of the

contain a selectable marker. Typical 5‘-3‘ regulatory

scription termination site, and/or a polyadenylation signal.

USA, 84:5345 (1987)); barley (Hordeum vulgarae; Wan and
Lemaux, Plant Physiol., 104:37 (1994)); maiZe (Zea mays;

Relevant Plants

polyadenylation signal Which functions in plant cells to
cause the termination of transcription and the addition of
polyadenylate nucleotides to the 3‘ end of the mRNA encod

(Asparagus o?icinalis; Bytebier et al, Proc. Natl. Acad. Sci.

45

Plant Transformation and Regeneration

Mimulus, Chamomile, Monarda, Solanum, Achillea,
Valeriana, Ocimum, Medicago, Aesculus, NeWcastelia,
Plumbago, Pityrogramma, Phacelia, Avicennia, Tamarix,
Frankenia, Limonium, Foeniculum, Thymus, Salvia,
Kadsura, Beyeria, Humulus, Mentha, Artemisia, Nepta,
Geraea, Pogogstemon, Majorana, Cleome, Cnicus,
Parthenium, Ricinocarpos, Parthenium, Hymenaea, Larrea,
Primula, Phacelia, Dryopteris, Plectranthus, Cypripedium,
Petunia, Datura, Mucuna, Ricinus, Hypericum, Myoporum,
Acacia, Diplopeltis, Dodonaea, Halgania, Cyanostegia,

duce such vectors into plant trichome, protoplasts, cells,
callus tissue, leaf discs, meristems, etc., to generate trans

Prostanthera, Anthocercis, Olearia, Viscaria. This promoter
might also be useful in plants having resin ducts, including
members of the genus: Pinus, Picea, Hedera, Heracleum,

genic plants, including Agrobacterium-mediated

Dorema, Solidago, Citrus, Eucalyptus, Ruta, Dictamnus,

transformation, particle gun delivery, microinjection,

Saururus, Typhonium, or Pseudotsuga.

Avariety of different methods can be employed to intro

electroporation, polyethylene glycol-mediated protoplast

Production of Transgenic Plants Comprising a Gene or

transformation, liposome-mediated transformation, etc. In

Multiple Genes of Interest
Plant transformation vectors capable of delivering DNA

general, transgenic plants comprising cells containing and
expressing DNAs encoding various enZymes can be pro
duced by transforming plant cells With a DNA construct as

55

DNAs) can be easily designed. Various strategies can be
employed to introduce these DNAs to produce transgenic
plants capable of biosynthesiZing high levels of a gene

described above via any of the foregoing methods; selecting
plant cells that have been transformed on a selective

product of interest including:

medium; regenerating plant cells that have been transformed
to produce differentiated plants; and selecting a transformed
plant Which expresses the enZyme-encoding nucleotide

(genomic DNAs, plasmid DNAs, cDNAs, or synthetic

60

1. Transforming individual plants With an encoding DNA
of interest. TWo or more transgenic plants, each con
taining one of these DNAs, can then be groWn and

sequence.
The DNAs can be introduced either in a single transfor
mation event (all necessary DNAs present on the same
present on separate vectors that are introduced into plants or

cross-pollinated so as to produce hybrid plants contain
ing the tWo DNAs. The hybrid can then be crossed With
the remaining transgenic plants in order to obtain a
hybrid plant containing all DNAs of interest Within its

plant cells simultaneously), or by independent transforma

genome.

vector), a co-transformation event (all necessary DNAs

65
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2. Sequentially transforming plants With plasmids con
taining each of the encoding DNAs of interest, respec

method Was used to prepare trichome glands for subtracting

gland versus leaf-minus-gland RNA. Mature leaves (about
40, average length 24 cm) of Nicotiana tabacum TL 1068
Were detached and immediately froZen in the atmosphere

tively.
3. Simultaneously cotransforming plants With plasmids
containing each of the encoding DNAs, respectively.
4. Transforming plants With a single plasmid containing

above a dry ice-ethanol slush. Once froZen, these Were
placed on a stainless steel incline, the bottom of Which Was

tWo or more encoding DNAs of interest.

submerged in a pool of liquid N2. Using a 2 inch hog-hair

5. Transforming plants by a combination of any of the
foregoing techniques in order to obtain a plant that
expresses a desired combination of encoding DNAs of
interest.

10

paint brush—brie?y dipped in liquid N2—leaves Were
brushed (doWn major veins) to detach glands (some With
stalks attached) and propel them into the liquid N2 pool.

Traditional breeding of transformed plants produced

After ?ltering through a metal screen into a mortar to

according to any one of the foregoing methods by successive
rounds of crossing can then be carried out to incorporate all

remove brush hair pieces, and evaporation of the liquid N2
(to about 2 mL), 100 ml of 2-mercaptoethanol Was added

the desired encoding DNAs in a single homoZygous plant
line (NaWrath et al, 1994; PCT International Publication WO

and the preparation Was ground to a ?ne poWder, maintain
15

93/02187).

Messenger RNA’s Were isolated from glands and cDNA’s
Were prepared. A commercial subtraction kit (PCR-Select
cDNA subtraction kit, CLONETECH LAB) Was used to

In methods 2 and 3, the use of vectors containing different
selectable marker genes to facilitate selection of plants
containing tWo or more different-encoding DNAs is advan
tageous. Examples of useful selectable marker genes include

those conferring resistance to kanamycin, hygromycin,

prepare gland-speci?c cDNA’s (subtracted gland cDNA’s
20

sulphonamides, glyphosate, bialaphos, and phosphinothri
Stability of Transgene Expression
As several overexpressed enZymes may be required to
25

may in?uence transgene expression in transformed plants.

Genomic clones of 1—31 Were isolated using a commer

problem.

cial tobacco genomic library. PCR based Walking Was used

One commonly employed approach is to select and/or

to determine the sequence and gene structure of the full
30

35

beta-glucuronidase (GUS) reporter gene, in frame, and intro
40

gration sites.
The use of enhancers from tissue-speci?c or
developmentally-regulated genes may ensure that expres
sion of a linked transgene or other encoding DNA occurs in

the appropriately regulated manner.
The use of different combinations of promoters, plastid
targeting sequences, and selectable markers in addition to
the trichome-speci?c regulatory sequence, for introduced

After determining 1852 base pairs, this sequence, along
With the coding region +1 to +111, Was fused With the

DNA With MAR elements may overcome problems associ
ated With differential base composition betWeen such trans

genes or encoding DNAs and integration sites, and/or the
detrimental effects of sequences adjacent to transgene inte

length genomic clones. A genomic clone of 1—31 shoWs 63
to 47% identity to the potato P450 at the amino acid and
DNA levels, respectively. PCR based Walking Was used to
determine the 5‘ sequence of the 1—31 gene in order to obtain
its promoter.

regard.
Inclusion of nuclear scaffold or matrix attachment regions
(MAR) ?anking a transgene has been shoWn to increase the
level and reduce the variability associated With transgene
expression in plants. Flanking a transgene or other encoding

stem-minus-gland total RNA’s, indicating its gland speci

?city.

Several strategies can be employed to avoid this potential
screen for transgenic plants that contain a single intact copy
of the transgene or other encoding DNA. Agrobacterium
mediated transformation technologies are preferred in this

from leaf-minus-gland cDNA’s). Trichome gland unique
cDNA’s obtained Were sequenced. One clone (1—31)
shoWed homology to P450 genes. Northern analysis shoWed
that this partial cDNA hybridiZed to total RNAs isolated
from gland, but not leaf-minus-gland, ?oWer, petal, root or

cm.

produce optimal levels, the phenomenon of co-suppression

ing liquid N2 temperature.

45

transgenes or other encoding DNAs can avoid potential
problems due to trans-inactivation in cases Where pyramid

duced into tobacco. Standard GUS staining of seedlings
shoWed that GUS Was expressed trichome-gland

speci?cally (FIG. 1). In FIG. 1, tissue ‘C’ is epidermis from
leaf of a non-transformed plant, and “P-GUS” is epidermis
from a similar aged leaf of a plant expressing the GUS
reporter gene driven by the isolated trichome
speci?cpromoter. Note the occurrence of GUS stain in
glands only. Some slight blue color Was also found in the
stalk cell immediately attached to the gland. This may
represent leakage of stain during tissue ?xation, or move
ment betWeen the gland and the ?rst stalk cell Within the
vacuolar-tubularcontinuum. No stain Was found in root,

stem, or any other tissue (not shoWn).

ing of different transgenes Within a single plant is desired.
Finally, inactivation by co-suppression can be avoided by
screening a number of independent transgenic plants to
identify those that consistently overexpress particular intro
duced encoding DNAs. Site-speci?c recombination in Which

We tested the speci?city of GUS expression in mature
plants to be sure there is no non-gland expression in, e.g.,

the endogenous copy of a gene is replaced by the same gene,

55 mature roots. The promoter-GUS construct Was introduced

but With altered expression characteristics, should obviate

into petunia, tomato and geranium to test the functionality of

Example 2

this problem.

the promoter in these non-tobacco, glanded trichome

Any of the foregoing methods, alone or in combination,
can be employed in order to insure the stability of transgene

bearing plants.

expression in transgenic plants of the present invention.

EXAMPLES

Example 1
A unique method for isolating trichome glands (glands
from glanded leaf hairs) Was used. A novel cold brushing

Example 3

60

The folloWing examples are offered by Way of illustration
of the present invention, and not by Way of limitation.

65

We transformed tobacco plants With the 1—31 cDNA in
antisense orientation. A plant Was found that had altered
trichome exudate chemistry consistent With a partial knock
out of a P450 function. This con?rmed the identity of the
1—31 gene. Further, the antisense plant had enhanced insect
resistance that is consistent With its altered exudate chem

istry.
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Utility

Example 4

Adeletion analysis (promoter dissection) of the upstream
region of an isolated trichome speci?c gene sequence to

deterimme tlfile cr1t1cal regions of the' péomoterr for II‘lChOIIli 5
g an 'specl C expresslon Was Came _ out‘

The DNA of the present invention has various potential
uses.

1_ Deploy (trichorne_gland_speci?cauy)disease_ and pest_

W0 FYPGS O

resistance-conferring proteins at the plant surface to

analyses Were made of plants expressing 10 deletion con-

increase resistance

structs plus the full-length construct. First, histochemical

Staining for GUS indicated that only deletions 4724,
-1413, and -1273 had GUS expression in glands, The 10
remainder ShOWC'd only trace GUS in the trichome stalk

_

$361113
Thglsi deéenon 2f the “1273 tofllzilreglgn 151651115‘;
1n osso g an -spec1 cpromoter activity. sot e rst
experiment testing _1852 to +1 With GUS, Where no g1and_
speci?c activity Was found.

_

useful
secondary products (e.g., pharmaceuticals, ?a
Vor and aroma Chemicals)‘

bp of the ?rst eXon (+1 to +111) is essential for gland-

speci?c promoter activity. This Was determined in another 15

'

2. Enhance trichome, natural-product-based pest/disease
resistance via trichome-speci?c metabolic engineering.
3_ Empoly trichorne glands as “factories” to produce
A1

4'

f

d

_

fh

_

1

1

ter ragraflce an aroma Propemes O _ Omcu tut?‘

and~food'(sp1ce) plants v1a tr1chome-spec1?c metabolic
englneenng
5. Employ trichome glands as “factories” to produce

Example 5

foreign proteins (e.g., phytotoXic proteins, proteins

Another deletion analysis involved isolating glands and 20

highlxsenslt?ve to modl?canon dunng lsolanon from

stalks from leaves of the 10 deletion-GUS plants and the
fun_1ength_GUS plant GUS activity Was monitored in
homogenates of these using methylumbelliferyl glucuronide

p ant nssue omogen?tes’ etc‘)
_
All of the references cited herein are incorporated by
reference 1n_the1r_ent1rety~
_
_

(MUG) substrate. Results are shoWn in FIG. 3. Activities

Those Sklned 1n the art W111 TeCOgmZe, or be able to

found in deletions _1123, _973, _823, _673, _523, _373, 25 ascertain using no more than routine experimentation, many
and -223 are attributed to staining in stalk cells and not
equivalents to the speci?c embodiments of the invention
glands. Thus, results of the histochemical and MUG assays
speci?cally described herein. Such equivalents are intended
Were consistent.
to be encompassed in the scope of the folloWing claims.

SEQUENCE LISTING

<l60> NUMBER OF SEQ ID NOs: 3

<210>
<2ll>
<2 12>
<2 13>
<220>
<22l>

SEQ ID NO 1
LENGTH: 1963
TYPE: DNA
ORGANISM: Nicotiana tabacum
FEATURE:
NAME/KEY: exon

<222> LOCATION:

(l853)..(l963)

<22l> NAME/KEY: CAATLsignal
<222> LOCATION:

(l669)..(l672)

<22l> NAME/KEY: TATALsignal
<222> LOCATION:

(l775)..(l778)

<22l> NAME/KEY: GCisignal
<222> LOCATION:

(l806)..(l807)

<22l> NAME/KEY: promoter
<222> LOCATION:

(l)..(l852)

<400> SEQUENCE: 1

taagttgata aagctaattt Ctcattttag Ctaccatcgc tagtaatcgt ggcaataact

60

accctaacta tagcatttat tgctaccaaa taaaatttgg Cagctaatca taattttttg

120

tcatgaatca atagttattg tagcaatagt tatctcttag Ccacaataaa ttatttaaaa

180

taaaatatta tagctaaata aatatttttg Ctttaagttc taaaaggttg tggcaatagt

240

taaatgatat agtcacagat ttattggtat aattgaatta tgttgctaat ttcttagttt

300

tttgccacga gttaaaaatt accaatagct atagtaactt tttaatcaca ataaaatatt

360

tgaaagaaaa tattgtagct aaatgaatat tttttccttc aagttattaa aagttgtggc

420

aatataggtt aaattagcca Catgtttctt gctttaatag aattttgtag Ctaatcatta

480

acttttacca Cgagttgaac ttaatataac aacaataacc ttttaaccat aataaagcga

540

tttaaatcaa atattactaa ataaataact ttgctttcaa gtttctataa aatcatggca

600
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-oontinued
atagtcatta Cgataaaatg atataaccac gaatatattg Caacgataaa ttctgtaact

660

aatcattagt ttttgcgacg aggtaaattt tCCgtCaCag tagcaatctt Ctaggcacat

720

taaaaatttg aaacaaaatt ttgtagtcaa ataaatattt atcttcttat tttaagaaaa

780

taaaaatagt tagataatag ttactactat ttgtcatgaa aatatcaata gatacaaatt

840

taaagtgact ataaatttac gagtttacta tactttagtc gtacagtttg Caataatagt

900

attttaacca Caattagtta tatgtacaaa ataacataag tgaataactt tttttcaatg

960

agaaaataag agttgctcaa acaatatcaa gttacaaaaa tttaatttta actgtaaaag

1020

ttatattttt ccaaaataac ataaactata gtaattatat atagtttgaa gtattaataa

1080

aatttaaata tgcaaaagtt aattttaata aaccatttgt atgcctaact tgtagcctct

1140

aaactatttt atttgcttta tttatcaaac tcatatttta ttttattgca ccttgttagt

1200

tttggacgtt aattatatat atttggtgta aaatttaaaa tatattaaca tttgtggaga

1260

atttatgtat gcctggttct taactatttt tttttatata actggttaga gtaatttctt

1320

atatttcagt atttattttt aaataagtcc tcataaattg aagactttaa aagtttttgt

1380

gtCattCCtC tttttattta agaaattgaa gaattccgct aaatttcata tttccgctgt

1440

tatttaactg tttatttCCC ttgttaatat aattggtaag aagttttaaa ataaaggagt

1500

taatgatttt Ctaggttcat ggcttgccta gcttctacga gtaagcgcca tCaCgaCtCC

1560

Cgaggataag gaaatccggg tcgtagcatt CaCtCaCaaa aattactaaa aacaaagttt

1620

aCCCttCtCC Caaaagtaaa tttcatattt ggCtCCaCat aatgtgttca atgagtcaag

1680

tgaagtactt ttcatgacaa aaaaaagttg Ctgaaaaatg Catatctcat attttttttt

1740

tagagaaatc CCatttCttg cctaaacgaa agcctataaa agagcatata ttgcaacaac

1800

agtttgcaga aactatcaag tcaaataatc CCCCCtttaa ttCCCtCCca aa atg Cag
Met Gln
1

1858

ttc ttc aac ttc ttt tCC ctt ttc ctt ttt gtg tCa ttt ctC ttt tta

1906

Phe Phe Asn Phe Phe Ser Leu Phe Leu Phe Val Ser Phe Leu Phe Leu
5
10
15
ttt aag aaa tgg aag aat tCC aat ago Caa aCC aaa aga ttg CCt CCa

1954

Phe Lys Lys Trp Lys Asn Ser Asn Ser Gln Thr Lys Arg Leu Pro Pro
20

25

30

ggt CCa tgg

1963

Gly Pro Trp
35

<2 10>
<211>
<212>
<213>
<220>

SEQ ID NO 2
LENGTH: 1852
TYPE: DNA
ORGANISM: Nicotiana tabacum
FEATURE:

<221> NAME/KEY: promoter
<222> LOCATION:

( 1) . . (1852)

<221> NAME/KEY: CAATisignal
<222> LOCATION:

( 1669 ) . . ( 1672)

<221> NAME/KEY: GCisignal
<222> LOCATION:

( 1806 ) . . ( 1807)

<400> SEQUENCE: 2

taagttgata aagctaattt Ctcattttag CtaCCatCgC tagtaatcgt ggcaataact

60

aCCCtaaCta tagcatttat tgctaccaaa taaaatttgg Cagctaatca taattttttg

120

tcatgaatca atagttattg tagcaatagt tatctcttag ccacaataaa ttatttaaaa

180

taaaatatta tagctaaata aatatttttg Ctttaagttc taaaaggttg tggcaatagt

240
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-continued

taaatgatat agtcacagat ttattggtat aattgaatta tgttgctaat ttcttagttt

300

tttgccacga gttaaaaatt accaatagct atagtaactt tttaatcaca ataaaatatt

360

tgaaagaaaa tattgtagct aaatgaatat tttttccttc aagttattaa aagttgtggc

420

aatataggtt aaattagcca catgtttctt gctttaatag aattttgtag ctaatcatta

480

acttttacca cgagttgaac ttaatataac aacaataacc ttttaaccat aataaagcga

540

tttaaatcaa atattactaa ataaataact ttgctttcaa gtttctataa aatcatggca

600

atagtcatta cgataaaatg atataaccac gaatatattg caacgataaa ttctgtaact

660

aatcattagt ttttgcgacg aggtaaattt tccgtcacag tagcaatctt ctaggcacat

720

taaaaatttg aaacaaaatt ttgtagtcaa ataaatattt atcttcttat tttaagaaaa

780

taaaaatagt tagataatag ttactactat ttgtcatgaa aatatcaata gatacaaatt

840

taaagtgact ataaatttac gagtttacta tactttagtc gtacagtttg caataatagt

900

attttaacca caattagtta tatgtacaaa ataacataag tgaataactt tttttcaatg

960

agaaaataag agttgctcaa acaatatcaa gttacaaaaa tttaatttta actgtaaaag

1020

ttatattttt ccaaaataac ataaactata gtaattatat atagtttgaa gtattaataa

1080

aatttaaata tgcaaaagtt aattttaata aaccatttgt atgcctaact tgtagcctct

1140

aaactatttt atttgcttta tttatcaaac tcatatttta ttttattgca ccttgttagt

1200

tttggacgtt aattatatat atttggtgta aaatttaaaa tatattaaca tttgtggaga

1260

atttatgtat gcctggttct taactatttt tttttatata actggttaga gtaatttctt

1320

atatttcagt atttattttt aaataagtcc tcataaattg aagactttaa aagtttttgt

1380

gtcattcctc tttttattta agaaattgaa gaattccgct aaatttcata tttccgctgt

1440

tatttaactg tttatttccc ttgttaatat aattggtaag aagttttaaa ataaaggagt

1500

taatgatttt ctaggttcat ggcttgccta gcttctacga gtaagcgcca tcacgactcc

1560

cgaggataag gaaatccggg tcgtagcatt cactcacaaa aattactaaa aacaaagttt

1620

acccttctcc caaaagtaaa tttcatattt ggctccacat aatgtgttca atgagtcaag

1680

tgaagtactt ttcatgacaa aaaaaagttg ctgaaaaatg catatctcat attttttttt

1740

tagagaaatc ccatttcttg cctaaacgaa agcctataaa agagcatata ttgcaacaac

1800

agtttgcaga aactatcaag tcaaataatc ccccctttaa ttccctccca aa

1852

<210>
<211>
<212>
<213>

SEQ ID NO 3
LENGTH: 1963
TYPE: DNA
ORGANISM: Nicotiana tabacum

<400> SEQUENCE: 3

taagttgata aagctaattt ctcattttag ctaccatcgc tagtaatcgt ggcaataact

60

accctaacta tagcatttat tgctaccaaa taaaatttgg cagctaatca taattttttg

120

tcatgaatca atagttattg tagcaatagt tatctcttag ccacaataaa ttatttaaaa

180

taaaatatta tagctaaata aatatttttg ctttaagttc taaaaggttg tggcaatagt

240

taaatgatat agtcacagat ttattggtat aattgaatta tgttgctaat ttcttagttt

300

tttgccacga gttaaaaatt accaatagct atagtaactt tttaatcaca ataaaatatt

360

tgaaagaaaa tattgtagct aaatgaatat tttttccttc aagttattaa aagttgtggc

420

aatataggtt aaattagcca catgtttctt gctttaatag aattttgtag ctaatcatta

480

acttttacca cgagttgaac ttaatataac aacaataacc ttttaaccat aataaagcga

540
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tttaaatcaa atattactaa ataaataact ttgctttcaa gtttctataa aatcatggca

600

atagtcatta cgataaaatg atataaccac gaatatattg caacgataaa ttctgtaact

660

aatcattagt ttttgcgacg aggtaaattt tccgtcacag tagcaatctt ctaggcacat

720

taaaaatttg aaacaaaatt ttgtagtcaa ataaatattt atcttcttat tttaagaaaa

780

taaaaatagt tagataatag ttactactat ttgtcatgaa aatatcaata gatacaaatt

840

taaagtgact ataaatttac gagtttacta tactttagtc gtacagtttg caataatagt

900

attttaacca caattagtta tatgtacaaa ataacataag tgaataactt tttttcaatg

960

agaaaataag agttgctcaa acaatatcaa gttacaaaaa tttaatttta actgtaaaag

1020

ttatattttt ccaaaataac ataaactata gtaattatat atagtttgaa gtattaataa

1080

aatttaaata tgcaaaagtt aattttaata aaccatttgt atgcctaact tgtagcctct

1140

aaactatttt atttgcttta tttatcaaac tcatatttta ttttattgca ccttgttagt

1200

tttggacgtt aattatatat atttggtgta aaatttaaaa tatattaaca tttgtggaga

1260

atttatgtat gcctggttct taactatttt tttttatata actggttaga gtaatttctt

1320

atatttcagt atttattttt aaataagtcc tcataaattg aagactttaa aagtttttgt

1380

gtcattcctc tttttattta agaaattgaa gaattccgct aaatttcata tttccgctgt

1440

tatttaactg tttatttccc ttgttaatat aattggtaag aagttttaaa ataaaggagt

1500

taatgatttt ctaggttcat ggcttgccta gcttctacga gtaagcgcca tcacgactcc

1560

cgaggataag gaaatccggg tcgtagcatt cactcacaaa aattactaaa aacaaagttt

1620

acccttctcc caaaagtaaa tttcatattt ggctccacat aatgtgttca atgagtcaag

1680

tgaagtactt ttcatgacaa aaaaaagttg ctgaaaaatg catatctcat attttttttt

1740

tagagaaatc ccatttcttg cctaaacgaa agcctataaa agagcatata ttgcaacaac

1800

agtttgcaga aactatcaag tcaaataatc ccccctttaa ttccctccca aaatgcagtt

1860

cttcaacttc ttttcccttt tcctttttgt gtcatttctc tttttattta agaaatggaa

1920

gaattccaat agccaaacca aaagattgcc tccaggtcca tgg

1963

What is claimed is:
1. An isolated nucleic acid molecule comprising:

7. A vector, comprising:

the polynucleotide sequence set forth in SEQ ID NO: 1;
or

a fragment of the polynucleotide sequence set forth in
SEQ ID NO: 1 comprising bases 578—1963 of SEQ ID
NO: 1, Wherein SEQ ID NO: 1 and said fragment have
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plant trichome gland speci?c transcriptional activity.
3. The nucleic acid molecule of claim 1, further compris
ing a polynucleotide sequence encoding a polypeptide.
4. The nucleic acid molecule according to claim 3,
Wherein said polypeptide is a disease- or pest-resistance

conferring protein.
5. The nucleic acid molecule according to claim 3,
Wherein said polypeptide is a pharmaceutical compound.
6. The nucleic acid molecule according to claim 3,
Wherein said polypeptide is a phytotoXic protein.

12. A transgenic plant comprising the nucleic acid mol
ecule of claim 1.

13. A transgenic seed comprising the nucleic acid mol

2. The nucleic acid molecule of claim 1, Which comprises

said fragment.

the isolated nucleic acid molecule of claim 1.
8. The vector of claim 7, Which is an eXpression vector.
9. The vector of claim 7, Which is a plant vector.
10. A host cell containing the vector of claim 7.
11. The host cell of claim 10, Which is a plant cell.

ecule of claim 1.
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14. A method for eXpressing a polypeptide comprising:
constructing a vector comprising the isolated nucleic acid
molecule of claim 1 operably linked to a nucleic acid

encoding a polypeptide; and
inserting said vector into a plant, Wherein said polypep

tide is expressed trichome gland speci?cally.
15. The transgenic plant of claim 12, Wherein the trans
genic plant is a food plant or horticultural plant.

